Haematopoietic stem cell transplantation for autoimmune diseases
JF Swart, EM Delemarre, F Van Wijk… - Nature Reviews …, 2017 - nature.com
Autologous haematopoietic stem cell transplantation (HSCT) is the only treatment that is
able to induce long-term, drug-free and symptom-free remission in several refractory …
able to induce long-term, drug-free and symptom-free remission in several refractory …
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …
achievable goal for most patients. Reaching this target leads to improved outcomes. The …
Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis
MJH Doeleman, EM Van Maarseveen… - Rheumatology, 2019 - academic.oup.com
Objective The clinical impact of anti-drug antibodies (ADAbs) in paediatric patients with JIA
remains unknown. This systematic review and meta-analysis aimed to summarize the …
remains unknown. This systematic review and meta-analysis aimed to summarize the …
Understanding inflammation in juvenile idiopathic arthritis: How immune biomarkers guide clinical strategies in the systemic onset subtype
JF Swart, S de Roock… - European journal of …, 2016 - Wiley Online Library
The translation of basic insight in immunological mechanisms underlying inflammation into
clinical practice of inflammatory diseases is still challenging. Here we describe how …
clinical practice of inflammatory diseases is still challenging. Here we describe how …
Predictors of health‐related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a web‐based survey
L Haverman, MA Grootenhuis… - Arthritis care & …, 2012 - Wiley Online Library
Objective Children with juvenile idiopathic arthritis (JIA) experience functional impairment
due to joint manifestations of the disease. The aim of our present study was to assess health …
due to joint manifestations of the disease. The aim of our present study was to assess health …
Factors associated with treatment response to etanercept in juvenile idiopathic arthritis
MH Otten, FHM Prince, W Armbrust, R ten Cate… - Jama, 2011 - jamanetwork.com
Context Since the introduction of biologic therapies, the pharmacological treatment
approach for juvenile idiopathic arthritis (JIA) has changed substantially, with achievement …
approach for juvenile idiopathic arthritis (JIA) has changed substantially, with achievement …
[PDF][PDF] Treatment to target using recombinant interleukin‐1 receptor antagonist as first‐line monotherapy in new‐onset systemic juvenile idiopathic arthritis: results from …
NM Ter Haar, EHP van Dijkhuizen… - Arthritis & …, 2019 - Wiley Online Library
Objective Systemic juvenile idiopathic arthritis (JIA) is a multifactorial autoinflammatory
disease with a historically poor prognosis. With current treatment regimens, approximately …
disease with a historically poor prognosis. With current treatment regimens, approximately …
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
JF Swart, EHP van Dijkhuizen, NM Wulffraat… - Annals of the …, 2018 - ard.bmj.com
Objectives To assess if the Juvenile Arthritis Disease Activity Score (JADAS71) could be
used to correctly identify patients with juvenile idiopathic arthritis (JIA) in need of antitumour …
used to correctly identify patients with juvenile idiopathic arthritis (JIA) in need of antitumour …
Definition and validation of the American College of Rheumatology 2021 juvenile arthritis disease activity score cutoffs for disease activity states in juvenile idiopathic …
C Trincianti, EHP Van Dijkhuizen… - Arthritis & …, 2021 - Wiley Online Library
Objective To develop and validate new Juvenile Arthritis Disease Activity Score 10
(JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive …
(JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive …
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register
MH Otten, J Anink, FHM Prince, M Twilt… - Annals of the …, 2015 - ard.bmj.com
Background Treatment of juvenile idiopathic arthritis (JIA) has changed dramatically since
the introduction of biological agents in 1999. Objective To evaluate trends in prescription …
the introduction of biological agents in 1999. Objective To evaluate trends in prescription …